1st Counsel – Lifestyle
Author:
Longeveron
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
April 8, 2026
Longeveron Announces 2025 Full Year Financial Results and Provides Business Update
March 18, 2026
Longeveron to Report 2025 Full-Year Financial Results and Host Conference Call on March 17, 2026
March 12, 2026
Longeveron Announces Closing of Private Placement of up to $30 Million
March 11, 2026
Longeveron Announces Private Placement of up to $30 Million
March 10, 2026